Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in chinese patients

Digestive Diseases and Sciences

Volumn 56, Issue 9, 2011, Pages 2750-2757

  Zhao, Dan Tong ^a,b   Liao, Hui Yu ^a   Liu, Yan Min ^a   Zhao, Yan ^a   Feng, Xia ^a   Yan, Hui Ping ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antimitochondrial antibody; Biliary; Liver cirrhosis; Prognosis; Survival analysis

Indexed keywords

IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ASSESSMENT TOOL; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MAYO RISK SCORE; MORTALITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CHINA; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 80054724622     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1661-7     Document Type: Article

References (35)

1. KD Lindor ME Gershwin R Poupon M Kaplan NV Bergasa EJ Heathcote 2009 American association for study of liver diseases. Primary biliary cirrhosis Hepatology 50 291 308 19554543 10.1002/hep.22906
2. ME Gershwin IR Mackay A Sturgess RL Coppel 1987 Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis J Immunol 138 3525 3531 3571977 1:CAS:528: DyaL2sXktFyktLw%3D (Pubitemid 17071942)
3. GL Wong AY Hui VW Wong FK Chan JJ Sung HL Chan 2005 A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients Am J Gastroenterol 100 2205 2211 16181370 10.1111/j.1572-0241.2005.50007.x
4. CW Su HH Hung TI Huo, et al. 2008 Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: A follow-up study up to 18 years Liver Int 28 1305 1313 18346129 10.1111/j.1478-3231.2008.01715.x 1:CAS:528: DC%2BD1cXht1CmtbjN
5. RK Wong SG Lim A Wee YH Chan MO Aung CT Wai 2008 Primary biliary cirrhosis in Singapore: Evaluation of demography, prognostic factors and natural course in a multi-ethnic population J Gastroenterol Hepatol 23 599 605 17645483 10.1111/j.1440-1746.2007.05058.x 1:CAS:528:DC%2BD1cXmsV2nsLk%3D (Pubitemid 351501141)
6. ER Dickson PM Grambsch TR Fleming LD Fisher A Langworthy 1989 Prognosis in primary biliary cirrhosis: Model for decision making Hepatology 10 1 7 2737595 10.1002/hep.1840100102 1:STN:280:DyaL1M3ptVKksA%3D%3D (Pubitemid 19169993)
7. M Prince A Chetwynd W Newman JV Metcalf OF James 2002 Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years Gastroenterology 123 1044 1051 12360466 10.1053/gast.2002.36027
8. A Parés L Caballería J Rodés 2006 Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 715 720 16530513 10.1053/j.gastro.2005.12.029 (Pubitemid 43374522)
9. MG Peters AM Di Bisceglie KV Kowdley, et al. 2007 Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States Hepatology 46 769 775 17654740 10.1002/hep.21759 (Pubitemid 47436123)
10. E Christensen 2004 Prognostic models including the Child-Pugh, MELD and Mayo risk scores-Where are we and where should we go? J Hepatol 41 344 350 15288486 10.1016/j.jhep.2004.06.005 (Pubitemid 39177643)
11. European Association for the Study of the Liver 2009 EASL clinical practice guidelines: Management of cholestatic liver diseases J Hepatol 51 237 267 10.1016/j.jhep.2009.04.009
12. P Invernizzi A Crosignani PM Battezzati, et al. 1997 Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis Hepatology 25 1090 1095 9141422 10.1002/hep.510250507 1:STN:280:DyaK2s3os1amtw%3D%3D (Pubitemid 27199932)
13. J Ludwig ER Dickson GS McDonald 1978 Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch A Pathol Anat Histol 379 103 112 150690 10.1007/BF00432479 1:STN:280: DyaE1c3ltF2qsg%3D%3D (Pubitemid 8388145)
14. RF Velázquez M Rodríguez CA Navascués, et al. 2003 Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 520 527 12601348 10.1053/jhep.2003.50093 (Pubitemid 36258772)
15. DR Cox 1972 Regression models and life tables J R Stat Soc B 34 187 220
16. B Liu XH Shi FC Zhang W Zhang LX Gao 2008 Antimitochondrial antibody-negative primary biliary cirrhosis: A subset of primary biliary cirrhosis Liver Int 28 233 239 18251980 10.1111/j.1478-3231.2007.01651.x (Pubitemid 351201037)
17. KT Fung J Fung CL Lai MF Yuen 2007 Etiologies of chronic liver diseases in Hong Kong Eur J Gastroenterol Hepatol 19 659 664 17625435 10.1097/MEG.0b013e3281ace0b7 (Pubitemid 47067064)
18. WR Kim KD Lindor GR Locke 3rd, et al. 2000 Epidemiology and natural history of primary biliary cirrhosis in a US community Gastroenterology 119 1631 1636 11113084 10.1053/gast.2000.20197 1:STN:280:DC%2BD3M%2Fnt1Cjsg%3D%3D (Pubitemid 32198688)
19. HP Yan H Zhuang YM Liu, et al. 2005 Immunological characteristics of primary biliary cirrhosis patients Zhonghua Gan Zang Bing Za Zhi 13 12 16 15670483 1:CAS:528:DC%2BD2MXhtFenurnL
20. EL Gu GB Yao 2009 The clinical characteristics of primary biliary cirrhosis in China: a systematic review Zhonghua Gan Zang Bing Za Zhi 17 861 866 19958649
21. H Liu Y Liu L Wang, et al. 2010 Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in South China BMC Gastroenterol 10 100 20815889 10.1186/1471-230X-10-100
22. Selmi C, Lleo A, Invernizzi P, Gershwin ME. Part III: Autoimmune liver diseases. Chapter 18: Primary biliary cirrhosis and autoimmune cholangitis. In: Gershwin ME, Jone MV, Michael PM, eds. Liver immunology: Principles and practice. Totowa, New Jersey: Humana; 2007:235-247.
23. K Inoue J Hirohara T Nakano, et al. 1995 Prediction of prognosis of primary biliary cirrhosis in Japan Liver 15 70 77 7791541 1:STN:280: DyaK2MzhtFKlsw%3D%3D
24. MM Kaplan ME Gershwin 2005 Primary biliary cirrhosis N Engl J Med 353 1261 1273 16177252 10.1056/NEJMra043898 1:CAS:528:DC%2BD2MXhtVeltLbI (Pubitemid 41345948)
25. MI Prince A Chetwynd WL Craig JV Metcalf OF James 2004 Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort Gut 53 865 870 15138215 10.1136/gut.2003. 023937 1:STN:280:DC%2BD2c3jvFyjug%3D%3D (Pubitemid 38662138)
26. ME Gershwin C Selmi HJ Worman, et al. 2005 Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients Hepatology 42 1194 1202 16250040 10.1002/hep.20907 (Pubitemid 43112687)
27. W Yang J Lu J Weng, et al. 2010 Prevalence of diabetes among men and women in China N Engl J Med 362 1090 1101 20335585 10.1056/NEJMoa0908292 1:CAS:528:DC%2BC3cXjvFyjt70%3D
28. T Hano 1968 Pathohistological study on liver cirrhosis in diabetes mellitus Kobe J Med Sci 14 87 106 5704884 1:STN:280:DyaF1M%2FovVKnsQ%3D%3D
29. MR Borgaonkar DG Morgan 1999 Primary biliary cirrhosis and type II autoimmune polyglandular syndrome Can J Gastroenterol 13 767 770 10633830 1:STN:280:DC%2BD3c%2FpvFKntQ%3D%3D (Pubitemid 30000147)
30. P Invernizzi C Selmi C Ranftler M Podda J Wesierska-Gadek 2005 Antinuclear antibodies in primary biliary cirrhosis Semin Liver Dis 25 298 310 16143945 10.1055/s-2005-916321 (Pubitemid 41254577)
31. M Nakamura Y Shimizu-Yoshida Y Takii, et al. 2005 Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis J Hepatol 42 386 392 15710222 10.1016/j.jhep.2004.11.016 1:CAS:528:DC%2BD2MXhtlens70%3D (Pubitemid 40254254)
32. M Nakamura A Komori M Ito, et al. 2007 Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis Hepatol Res 37 s412 s419 17931196 10.1111/j.1872-034X.2007.00244.x 1:CAS:528:DC%2BD2sXhtlyrtLrI (Pubitemid 47570654)
33. HJ Worman 2007 Nuclear envelope protein autoantigens in primary biliary cirrhosis Hepatol Res 37 S406 S411 17931195 10.1111/j.1872-034X.2007.00227.x 1:CAS:528:DC%2BD2sXhtlyrtLrO (Pubitemid 47570653)
34. XF Liang YS Chen XJ Wang, et al. 2005 A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old Zhonghua Liu Xing Bing Xue Za Zhi 26 655 658 16471211
35. O Chazouilleres D Wendum L Serfaty S Montembault O Rosmorduc R Poupon 1998 Primary biliary cirrhosis-autoimmunehepatitis overlap syndrome: Clinical features and response to therapy Hepatology 28 296 301 9695990 10.1002/hep.510280203 1:CAS:528:DyaK1cXlsFGgu7c%3D (Pubitemid 28363652)